BACKGROUND OF THE INVENTION
Decreased cerebral blood flow (CBF) is a significant problem seen in the most common and devastating brain disorders, including chronic hydrocephalus, stroke and dementia. Increasing clinical and experimental evidence indicate that the underlying cause in these and other
BRIEF SUMMARY
Embodiments of the present invention are directed toward novel compounds of the formula (I),
##STR00001##
and hydrates, solvates, enantiomers, diastereomers, pharmaceutically acceptable salts, prodrugs and complexes thereof, wherein:
X and Y are each independently CH and connected by a